Asthma exacerbations are best prevented by long-term treatment with inhaled corticosteroids (ICS), and add-on therapy as required. This should be in conjunction with treatment of modifiable risk factors such as avoidance of known asthma triggers (e.g., allergens and cigarette smoking) and treatment of comorbidities such as obesity and anxiety.[106]Chauhan BF, Jeyaraman MM, Singh Mann A, et al. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD010347.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010347.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/28301050?tool=bestpractice.com
[157]Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018 Apr;141(4):1169-79.
https://www.jacionline.org/article/S0091-6749(18)30282-3/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/29627041?tool=bestpractice.com
Add-on medical therapy (most commonly with a long-acting bronchodilator) not only improves asthma control but has been shown to reduce asthma exacerbations.[158]FitzGerald JM, Gibson PG. Asthma exacerbations. 4: prevention. Thorax. 2006 Nov;61(11):992-9.
https://thorax.bmj.com/content/61/11/992.long
http://www.ncbi.nlm.nih.gov/pubmed/17071835?tool=bestpractice.com
For adults who have persistent asthma, but who have suboptimal control of their asthma despite daily use of an ICS, the addition of an LTRA can help to reduce moderate and severe asthma exacerbations and improve lung function and asthma control compared with the same dose of ICS alone. However, current evidence does not support LTRAs as an ICS-sparing agent.[106]Chauhan BF, Jeyaraman MM, Singh Mann A, et al. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD010347.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010347.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/28301050?tool=bestpractice.com
The use of a written, personalised asthma action plan should be strongly encouraged to support self-management.[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
[56]National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. Mar 2021 [internet publication].
https://www.nice.org.uk/guidance/ng80
[147]Ring N, Malcolm C, Wyke S, et al. Promoting the use of personal asthma action plans: a systematic review. Prim Care Respir J. 2007 Oct;16(5):271-83.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634230
http://www.ncbi.nlm.nih.gov/pubmed/17710351?tool=bestpractice.com
Asthma and Lung UK: adult asthma action plan
Opens in new window The asthma action plan helps patients to recognise when their asthma is deteriorating and how to respond appropriately: for example, increasing usual reliever and controller treatment, starting a short course of oral corticosteroids, and determining when to seek medical help.[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
Guidelines also recommend treating modifiable risk factors and comorbidities (e.g., smoking, obesity, anxiety) and giving advice about non-pharmacological therapies and strategies when appropriate (e.g., physical activity, weight loss, avoidance of triggers).[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
[56]National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. Mar 2021 [internet publication].
https://www.nice.org.uk/guidance/ng80
They also recommend checking inhaler technique and adherence frequently.[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
[56]National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. Mar 2021 [internet publication].
https://www.nice.org.uk/guidance/ng80
Vaccination schedules vary by location; consult local guidance for recommendations. Further information on UK and US vaccines, and special patient populations, can be found in their respective vaccination schedules.
UKHSA: complete routine immunisation schedule
Opens in new window
CDC: ACIP recommendations
Opens in new window Specific UK considerations:
Pneumococcal vaccinations are recommended for people with severe persistent asthma (including those who require frequent hospitalisation).[159]UK Health Security Agency. Complete routine immunisation schedule. Oct 2023 [internet publication].
https://www.gov.uk/government/publications/the-complete-routine-immunisation-schedule
[160]UK Health Security Agency. Influenza: The Green Book, chapter 19. Sep 2022 [internet publication].
https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19
Annual influenza vaccinations are recommended for people with asthma in the UK. Despite previous concerns that influenza vaccines might precipitate asthma attacks, current evidence suggests that this risk is very low.[161]Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000364.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000364.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/23450529?tool=bestpractice.com
[
]
In people with mild to moderate asthma, how do flu vaccines affect asthma symptoms?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.911/fullShow me the answer Influenza vaccination has not been shown to protect against asthma exacerbations.[161]Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000364.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000364.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/23450529?tool=bestpractice.com
All patients with poorly controlled asthma should be up-to-date with coronavirus disease 2019 (COVID-19) vaccination.[162]UK Health Security Agency. COVID-19: The Green Book, chapter 14a. Apr 2023 [internet publication].
https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a